Adjuvant endocrine therapy for perimenopausal women with early breast cancer
Authors:
- Olaf OrtmannOlaf Ortmann
- Tanja CuferTanja Cufer
- J. Michael DixonJ. Michael Dixon
- Nicolai MaassNicolai Maass
- Paolo MarchettiPaolo Marchetti
- Olivia PaganiOlivia Pagani
- Paolo PronzatoPaolo Pronzato
- Vladimir SemiglazovVladimir Semiglazov
- Jean-Philippe SpanoJean-Philippe Spano
- Eduard VrdoljakEduard Vrdoljak
- Hans WildiersHans Wildiers
Open Access
- 28 February 2009
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 18 (1) , 2-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy for Breast CancerJournal of Clinical Oncology, 2006
- Identifying menopause in breast cancer patients: considerations and implicationsBreast Cancer Research and Treatment, 2006
- Adjuvant Systemic Therapy in Young WomenBreast Disease, 2006
- Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and LessonsClinical Breast Cancer, 2006
- Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested GuidelinesJournal of Clinical Oncology, 2006
- Gonadotropin‐releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinomaCancer, 2005
- Adjuvant Endocrine Therapy for Premenopausal Women With Early Breast CancerJournal of Clinical Oncology, 2005
- American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004Journal of Clinical Oncology, 2005
- Aromatase inhibitors: mechanism of action and role in the treatment of breast cancerSeminars in Oncology, 2003
- Aromatase Inhibitors in Breast CancerNew England Journal of Medicine, 2003